肝炎病毒感染对肾移植患者肝损害的临床观察

To analyze the influence of hepatic virus infection on renal allograft recipients. The 42 patients infected hepatitis virus (positive group) and 144 patients without infection (negative group) were treated with similar immunosuppressive agents and liver protection medicine, lamivudine were added to those HBV-DNA positive. Moreover, liver function?viral sign and medical concentration were periodically tested. The result showed that the incidence rate of medical liver damage lead by different hepatitis virus infection were significantly higher than those without it. If liver dysfunction exist before operation, the incidence rate and the degree of liver damage were higher and severer. This suggested that the incidence of liver damage in those renal recipients infected HBV should be advocated to be on guard.